Pilar Enriquez pilarfjq972730
  • https://gitea.tecamino.com/monserrateruck
  • In 1965, the FDA pressured CIBA to further document its legitimate medical uses, and re-approved the drug for treating post-menopausal osteoporosis and pituitary-deficient dwarfism.

  • Joined on 2026-03-29
No matching results found.